NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 14,870
+80 (0.54%)
At close: Sep 9, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 169.04 billion as of September 9, 2026. Its market cap has decreased by -43.38% in one year.
Market Cap
169.04B
Enterprise Value
156.44B
Revenue
22.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,870.00
ChartMarket Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 169.04B, an increase of 351.57%. That is a compound annual growth rate of 10.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 169.04B | -60.38% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 209.42B |
| Kangstem Biotech | 207.86B |
| Kanaph Therapeutics | 185.94B |
| Genome & Company | 176.25B |
| Bio Solution | 169.28B |
| TiumBio | 143.88B |
| Ensol Biosciences | 143.76B |
| ISU Abxis | 140.47B |